CIRCULATION CONTROL
Print ISSN : 0389-1844
original articles
The Study of Treatment for the Inhibition of Cardiac Function due to Levobupivacine
Kazuya UrashimaShiori TeraiTakako NishihoriYoshihiko HirotaniKazuhiko Tanaka
Author information
JOURNAL FREE ACCESS

2004 Volume 25 Issue 2 Pages 169-175

Details
Abstract
Levobupivacaine is a long acting, amide-type local anaesthetic that is the S(−)-isomer of the racemate bupivacaine. It has high affinity for the myocardial Na+ channel that can be cardiotoxic. So, an intravenous injection of levobupivacaine sometimes becomes a serious problem as the inhibition of cardiac function.
Then, we investigated the effects of cardiac pacing and catecholamines(epinephrine, norepinephrine, isoproterenol) to treat the inhibition of cardiac function in isolated rat hearts.
Our results showed that cardiac pacing and 0.8μg/kg/min epinephrine recovered the inhibition of cardiac function due to 5μg/ml levobupivacaine.
Content from these authors
© 2004 by Japan Society of Circulation Control in Medicine
Previous article Next article
feedback
Top